4D Path
PrivateLast Round
Strategic
May 5, 2026
Total Funding Raised
$4.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
4D Path is a biotechnology company that has developed a patented, AI-powered precision diagnostics platform called the Q-Plasia OncoReader (QPOR™) to predict a patient's response to cancer treatment by analyzing digitized images from standard H&E-stained biopsies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
4D Path Comparables
Compare 4D Path with similar companies based on industry and business-model similarity.
4D Path Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 5, 2026 | ||||
| Series A | Jan 24, 2023 | ||||
| Seed | Dec 10, 2019 |
Key People
Founding team and executive leadership
4D Path Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARTIS Ventures | Series A |
| Vesalius Biocapital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
Completed a strategic funding round.
4D Path Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 4D Path's valuation, stock price, and market status.